To design effective vaccines, researchers leverage the natural powers of the body’s immune system. The immune system is a complex array of cells and systems that work to identify and eliminate infectious organisms (such as viruses) in the body. It does this in a lot of different complex way...
However, one advantage of live virus vaccines is that they tend to provoke a very strong immune response that lasts a long time. It’s easier to design a one-shot vaccine using a live virus vaccine than with some other vaccine types. These vaccines are also less likely to require the use...
Guillain Barré syndrome (a neurological disorder in which the body’s immune system damages nerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who have received the Janssen COVID-19 Vaccine. In most of these people, symptoms began within 42 days following r...
An antibody test is a screening for things called antibodies in your blood. Your body makes these when it fights an infection, such as COVID-19. The same thing happens when you get a vaccine, such as a flu shot. That’s how you build immunity to a virus. 1800x1200_covid_19_antibod...
Coronavirus disease 2019 (COVID-19), the pandemic infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents with an extremely heterogeneous spectrum of symptoms and signs. The clinical manifestations seem to be correl
It's important for expecting moms to stay up to date with their COVID-19 vaccines, which means getting the latest shot when it's time. Your healthcare provider can help you with the timing. Here's why it's so important to get your COVID vaccine during pregnancy: The vaccine lowers th...
U.S. CDC still Looking at Potential Stroke Risk from Pfizer Bivalent COVID Shot|Reuters. Available online: https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-still-looking-potential-stroke-risk-pfizer-bivalent-COVID-shot-2023-01-26/ (accessed on 2 February 2023). Xie, Y.; ...
Johnson & Johnson’s one-shot vaccine appears to be highly effective against severe COVID-19 and received Emergency Use Authorization in the United States on February 27.112 Novavax’s vaccine is now in Phase III trials; preliminary results suggest it was highly effective in the United Kingdo...
Hence, these patients should receive a 4 shot series.Efficacy of COVID-19 vaccines in patients with plasma cell dyscrasia.AuthorStudy, YearStudy Populationn/NVaccineOverall Seropositive %On Therapy Seropositive %Not on Therapy Seropositive %CD-38 TherapySeropositive %SMM Seropositive %AgeSero...
A rendering of LA remdesivir has the potential as a “flu-shot-like” injectable product to cover or treat patients for a 5-days or one-week treatment, possibly without the need for hospitalization. Given the rapid, massive, and evolving information reported over the past months, it is ...